Effects of 8-Week CrossFit-Based Concurrent Training on Fitness, Body Composition, and Psychological Outcomes in Schoolchildren

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-11
SponsorMaimónides Biomedical Research Institute of Córdoba

About this trial

This study examines the effects of an 8-week CrossFit-based concurrent training program in boys and girls aged 7 to 11 years, comparing an experimental group (n=15) with a control group (n=15). The aim is to assess changes in strength, cardiorespiratory fitness, body composition, and psychological variables such as anxiety, stress, and self-esteem, using field-based physical tests (CMJ, Course Navette, handgrip strength, etc.) and validated questionnaires. The study follows a randomized controlled trial design with pre- and post-intervention assessments. The experimental group will complete two weekly CrossFit sessions adapted for children, while the control group will maintain their usual routine without structured physical training. The hypothesis states that the intervention will significantly improve both physical performance and psychological well-being in the experimental group compared to the control group.

Eligibility criteria

Qualifiers

Age: 7-11 years.

Students enrolled at CEIP Pablo García Baena (Córdoba).

Availability to attend the Triple XXX Box (Polígono Pedroches, C. los Alfareros, Parcel 119, 14014 Córdoba), where both assessments and training sessions will be conducted.

Availability to attend training sessions twice per week for the 8-week intervention period.

Disqualifiers

Children with musculoskeletal injuries, diseases, or medical, psychological, or behavioral conditions that limit physical activity or interfere with the assessment of outcomes.

Inability or anticipated difficulty in regularly attending training sessions.

Refusal of parents or legal guardians to provide informed consent.

Trial design

Treatments tested in this trial

  • CrossFit training

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Maimónides Biomedical Research Institute of Córdoba

Lead sponsor

Universidad de Córdoba

Collaborator

Escuela Universitaria de Osuna

Collaborator